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-
Clinical orthotopic liver transplantation-removal of the entire liver 
and its replacement with a homograft-was first performed on March 1, 
1963 at the University of Colorado. During the next 13 years, approxi-
mately 265 such procedures have been performed throughout the world. 
The University of Colorado series now numbers 113 patients, or about 40 
per cent of the total experience ~fn a recen t extensive review, our first 93 
cases were analyzed in detail, emphasizing clinical and pathologic corre-
lations." 
In this article, we will focus upon certain areas ofaur experience; our 
results with thfs procedure, our present views regarding candidacy for 
liver replacement, and finally, selected diagnostic and technical problems 
that are encountered during and after liver transplantation, particularly 
the problem of secondary jaundice\ 
, 
SURVIVAL AFTER LIVER TRANSPLANTATION 
Of the 113 patients in the University of Colorado series, 103 were 
transplanted more than 1 year ago. Of these 103 at risk, 30 (or 29 per cent) 
have survived for at least 1 year after liver replacement (Table 1). 
Since 1968 the I-year survival figures have been relatively constant 
from year to year. Despite the very heavy early mortality, one which must 
be considered unacceptable, many of the patients who have reached the 
I-year mark have continued to do welL For example, 15 of the 30 I-year 
survivors are still alive. Fifteen patients have reached the 2-year mark, 
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Table 1. Su rvival After Liver Transplantation at the University 
of Colorado" 
UVED 
ALIVE 
NUMBER 1 Year 2 Years 3 Years 4 Years 5 Years NOW 
1963-1966 6 0 0 0 0 0 0 
1967 6 1 0 0 0 0 0 
1968 12 5 2 1 0 0 0 
1969 6 2 1 1 It 0 
1970 10 2 1 1 1 1: 
1971 11 2 2 2 2 2 2 
1972 11 5 3 2 2 0 2 
1973 13 3 3 1 0 0 2 
1974 20 8 3 0 0 0 6 
1975 8 2 0 0 0 0 2 
103 30 15 8 6 4 15 
'Only patients in risk for 1 year are included. 
tDied 5H years. 
:Alive ~ years. 
l 
eight have reached 3 years, six have sbrvived 4 years, and there have been 
four 5-year survivors (see Table 1). Our longest survivor, who is now 6% 
years post-transplantation, is living at home, attending school, and has 
absolutely normal liver function. Two other 5-year survivors are also 
entirely well, but the fourth one died a few days short of the 6-year mark of 
chronic rejection and partial biliary obstruction. Of the 15 I-year sur-
vivors who subsequently died, four have succumbed to recurrent tumor, 
five to chronic rejection, and two each-died of hepatitis, of bile duct 
obstruction, and of septic complications unrelated to biliary tract prob-
lems (Table 2). In retrospect, at least some of these late deaths might have 
been avoided, particularly those caused by failure of biliary drainage. 
CANDIDACY FOR LIVER TRANSPLANTATION 
INFLUENCE OF AGE 
Not surprisingly, older patients have a poorer prognosis after liver 
transplantation. For example, during the 5-year period 1969-1974, only 
13 per cent of recipients over 40 years of age survived a year or more 
Table 2. Present Status 0[30 l-Year Survivors 
Alive 15130 
Dead 15/30 
12 months to 80 months 
12 months to 71 months 
Recurrent cancer 
Chronic rejection 
Chronic hepatitis 
Bile duct obstruction 
Other infections 
4 
5 
2 
2 
2 
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Table 3. One-Year Survival by Age (1969-1974) 
AGE NO. I-YEAR PER CENT 
(YEARS) PATIENTS SURVIVAL SURVIVING 
o to 5 24 9 38 per cent 
6 to 15 10 3 30 per cent 
16 to 25 9 6 67 per cent 
26 to 40 10 4 40 per cent 
41 + 16 2 13 per cent 
TOTAL 69 24 35 per cent 
Patient .. 40 years 53 22 42 per cent 
after operation versus 42 per cent for those 40 years or younger (Table 3). 
The much increased mortality in these older recipients has largely been 
the consequence of pulmonary or other infections, difficulties with main-
taining nutrition, or neurologic complications. 
INFLUENCE 6F HEPATIC DISEASE 
Transplantation for Hepatic Malignancy 
Early in our experience, nonresectable hepatic malignancies were a 
popular indication for liver replacement. In the University of Colorado 
series, 12 patients have been transplanted for nonresectable hepatoma, 
cholangiocarcinoma, or hemangioendothelial sarcoma. There were 
seven early deaths not related to malignancy. The other five patients, 
however, all died of recurrence, 87 'to 432 days after transplantation. 
Usually, widespread pulmonary metastases developed and, typically, the 
grafted livers were also involved by malignancj. Because of this tendency 
to develop recurrence, we believe that patients with large nonresectable 
malignant tumors are questionable candidates for liver replacement. Ex-
ceptions to this policy of exclusion have been made w hen the tumor is an 
incidental finding in a liver afflicted with another disease. For example, 
one of our patients transplan ted for biliary atresia had a small hepatoma 
in the excised organ. She has absolutely no evidence of recurrence 60/3 
years after transplantation and, in fact, is our longest survivor. 
Another kind of malignancy which we tTIitially thought might be a 
good indication for liver transplantation is the so-called "Klatskin tu-
mor."2 These small duct cell carcinomas usually arise at the bifurcation 
of the hepatic ducts and kill by obstruction, rather than by widespread 
disease (Fig. 1). Of the four patients we have transplanted for this indi-
cation, two died early after operation. One of the other two patients is 
alive and clinically free of tumor 2 years post-transplantation. The other, 
however, died of recurrent tumor in his transplanted liver 2 years 
after operation. Thus, we are unsure of the long-term prognosis in such 
cases but we believe that further trials in younger patients with this 
malignancy are warranted, since liver replacement is the only procedure 
with the likelihood of cure. Those patients with Klatskin tumors who are 
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Figure 1. Preoperative transhepatic cholangiogram of a very small duct cell tumor at the 
bifurcation of the hepatic ducts (arTOws). Liver replacement was successfully performed but 
the patient died of recurrent tumor 2 years later. 
not candidates for transplantation can often be effectively palliated, as 
has been so well demonstrated by Terblanche. 5 
Benign Hepatic Diseases 
BILIARY ATRESIA. Children with biliary atresia were originally 
thought to be ideal candidates for liver transplantation; this has not 
always proved to be so in individual cases. Although these children usu-
ally enjoy relatively good health until late in the course of their disease, 
this advantage has in some patients been more than offset by technical 
difficulties at the time of transplantation. Congenital anomalies of the 
hepatic vasculature, which are not uncommon in patients with biliary 
atresia, have made it difficult or impossible to revascularize the homo-
graft livers in some instances. In other children, technical problems 
posed by the need to work with tiny vessels contributed to failure. These 
latter difficulties have been at least partially circumvented by the adop-
tion of microsurgical techniques. 
It is worth pointing out that we believe that the Kasai procedure (or 
porticoenterostomy) for biliary atresia and liver transplantation are com-
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plementary and not competitive procedures. Even when bile drainage 
cannot be achieved, the Kasai procedure does not preclude subsequent 
transplantation. In those patients with progressive cirrhosis despite the 
successful establishment of bile flow, the porticoenterostomy has suc-
cessfully "bought time" for the patient, enabling him to grow and develop, 
thus making the task of transplantation easier. More importantly, by 
prolonging survival the period of candidacy for transplantation is 
lengthened. This is obviously particularly important in these young can-
didates for transplantation for whom potential donors are few and far be-
tween. One of our patients, for example, underwent a Kasai procedure at 
4 months of age. At 44 months, a liver biopsy showed severe cirrhosis 
and the patient was referred for transplantation, which was carried out 
15 months later. She now has normal liver function, nearly 3 years post-
transplantation (Fig. 2). 
ALCOHOLIC CIRRHOSIS. Through the years, our worst results have 
been in patients with alcoholic cirrhosis. Of ten alcoholics transplanted, 
only one, a former professional football player, has achieved long-term 
survival. If the patient has completely repudiated the use of alcohol, there 
should be no intrinsic contraindication to transplantation. In practice, 
however, the uncertain course of the disease has usually resulted in 
consideration for transplantation being delayed until such time as one-or 
more complications has supervened. Thus, these patients are usually not 
referred until repeated episodes of gastrointestinal bleeding, pneumollij:is 
and other infectious complications, or severe hepatic encephalopathy 
have occurred, thereby severely jeopardizing the chances for recovery. 
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Improvement in survival after transplantation in this group of patients 
will therefore require that these patients be considered for the procedure 
before these complications are present and while the candidate still en-
joys relatively good health. 
CHRONIC AGGRESSIVE HEPATITIS. In contrast, those patients with 
postnecrotic cirrhosis or chronic aggressive hepatitis have a much more 
favorable prognosis. These patients are usually younger than those with 
alcoholic cirrhosis. Moreover, the downhill course of their disease is gen-
erally more predictable. Those patients with a negative hepatitis B anti-
gen preoperatively do not seem to have a significant risk of developing 
recurrent hepatitis postoperatively. 
The spectre of recurrent hepatitis looms more ominously if the indica-
tion for transplantation is HB. Ag positive hepatitis. One of our patients 
transplanted for this disease developed acute, antigen-positive hepatitis 
postoperatively, which progressed to chronic active hepatitis from which 
she eventually died. In two patients with antigen-positive hepatitis 
treated subsequently, high titer anti-HBs Ag antiserum was given intra-
and postoperatively. Preliminary observations suggest that the antiserum 
was successful in eliminating antigen remaining after removal of the 
infected liver. Whether this precaution will prevent the subsequent oc-
currence of post-transplantation hepatitis can only be answered by future 
trials, since neither patient survifed the early convalescent period. 
INBORN ERRORS OF METABOLISM. Certain hepatic-based inborn er-
rors of metabolism appear to be especially favorable indications for liver 
transplantation. We have had experience with two such diseases: Wil-
son's disease and alpha)"antitrypsin deficiency. 
In Wilson's dise ase, there is a congenital defect of copper metabolism, 
which is frequently accompanied by hepatic cirrhosis. Both patients that 
we have transplanted for this indication have survived 5 years, although 
one of them died shortly before the 6.year mark of chronic rejection and 
bile duct obstruction. In both patients, transplantation of a normal liver 
cured the metabolic defect. Ceruloplasmin, which was quite low 
preoperatively, rose to the normal range. Copper metabolism became 
normal, and there has been no tendency to reaccumulate copper in the 
homo grafts. Moreover, the neurologic stigmata of Wilson's disease 
gradually disappeared. 
Alpha,-antitrypsin deficiency is a hereditary disease in which the 
homozygous phenotype, Pizz, predisposes to congenital infantile cirrho-
sis and occaSionally adult cirrhosis, pulmonary emphysema of early on-
set in adults and, rarely, both pulmonary and hepatic disease either in 
childhood or adult life. The PizZ phenotype is not terribly rare; its inci-
dence is estimated to be about one in-2500 live births, about the same as 
that of cystic fibrosis. About 20 to 30 per cent of children who have the 
PizZ phenotype will go on to develop cirrhosis. The cause for the cirrhosis 
is not known, but observations after liver transplantation for this disease 
indicate that the liver is the sole source of the missing alpha,-antitryp-
sin.3 
We have transplanted a I6-year-old girl with alpha,-antitrypsin de-
ficiency. Postoperatively, she developed normal levels of alpha,-
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Table 4. Serum Alpha.-Antitrypsin Concentration and 
Phenotypes Before and After Liver Transplantation 
POST-
TRANSPLANT 
367 
AFTER 
PRETRANS- FIRST SECOND RETRANS-
PLANT DONOR l8mo. 27 mo. DONOR PLANT 
Phenotype ZZ MM MM MM MZ MZ 
Concentration (mg per cent) 55 264 256 176 270 
(normal 140-470) 
antitrypsin, adopting the donor phenotype, PiMM (Table 4). Two years after 
transplantation her graft failed from chronic rejection. The donor for her 
second transplant by coincidence had the heterozygous PiMZ phenotype 
and a correspondingly reduced serum alpha.-antitrypsin concentration 
(heterozygotes, however, have no predilection to develop liver disease). 
Following the retransplantation, the recipient's serum again adopted the 
liver donor's phenotype, this time PiMZ (see Table 4). Although the patient 
died a month later ofpulmonarY'mfectlous complications, the validity of 
the metabolic correction by liver transplantation for this disease was 
establish-ed. 
Daloze1 has reported the metabolic cure of a third liver-based, inborn 
error of metabolism, Niemann-Pick disease. Recently we have trans-
planted a child with tyrosinemia who also had a hepatoma in her cirrhotic 
liver. Biochemical studies are underway, but this may prove to be a fourth 
inborn error treatable by liver repla~mentK 
OTHER BENIGN DISEASES. Successful liver replacement has also 
been carried out for primary biliary cirrhosis and the Budd-Chiari syn-
drome. We have not yet successfully transplanted patients for fulminant 
liver failure from hepatitis or other toxic agents. A major logistical prob-
lem in the latter cases involves finding an appropriate cadaveric organ 
donor during the very brief time span in which such patients are legiti-
mate candidates for transplantation. 
IMMUNOLOGIC CRITERIA FOR DONOR-RECIPIENT SELECTION 
Unlike patients with end-stage renal disease, candidates for liver 
transplantation have no artificial support system comparable to 
hemodialysis available to them. Consequently, their period of candidacy 
for liver transplantation is necessarily shorter, requiring a relaxation of 
criteria for donor-recipient selection, if they are to be treated at all. Indeed, 
if the deteriorating condition of the recipient warrants doing so, all ordi-
nary immunologic restrictions may be ignored and an ABO incompatible 
or cytotoxic-crossmatch positive organ inserted. Under less pressing cir-
cumstances, however, the following guidelines are observed. 
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ABO Compatibility 
The criteria for ABO selection of recipients are identical to those for 
transplantation of other organs such as the kidney. If these red cell 
barriers are violated in renal transplantation, hyperacute rejection of the 
organ is the usual, although not invariable, consequence. This does not 
appear to be the case after liver transplantation. Seven of our patients 
have received ABO incompatible organs (Table 5). Hyperacute rejection 
did not occur in any of these recipients and all but one survived at least a 
month postoperatively. It is unclear from this experience whether these 
organs may be more susceptible to late rejection, but it is clear that 
hyperacute rejection of the human liver is quite uncommon, if it occurs 
at all. 
Cytotoxic Antibody Crossmatches 
The presence of preformed antidonor antibodies, as demonstrated by 
a positive cytotoxic crossmatch, likewise nearly invariably forecasts 
hyperacute rejection of renal homografts. Again the liver seems quite 
resistant to this immunologic complication, since placement of a hepatic 
homograft in this immunologically hostile environment does not seem to 
cause its immediate rejection and the long-tenn prognosis of such pa-
\ 
tients appears no different than those with a negative crossmatch. 
HL-A Tissue Typing 
The results of histocompatibility matching in our first 103 cases are 
given in Table 6. No effort has been made to select HL-A compatible 
donor-recipient combinations, a policy clearly reflected by the very small 
number of good matches. Witnsuch askewed spectrum of his to com pat i-
bility, meaningful conclusions about the validity of the techniques used 
cannot be drawn. Nonetheless, there is no definable correlation between 
the quality of match and survival. Obviously, conclusions about the valid-
ity of HL-A matching are far more likely to come from experience with 
renal transplantation in which there is much greater flexibility of donor-
recipient pairing. 
Table 5. Results with Seven ABO-Incompatible Liver Transplants 
ABO TYPES PREOPERATIVE 
OT ISOAGG. 
NO. Donor Recipient TITER OUTCOME 
59 AB A 1:4 (Anti-B) Died 173 days 
60 AB A 1:32 (Anti-B) Died 61 days 
71 A 0 1 :512 (Anti-A) Died 41 days 
98 A 0 1:128 (Anti-A) Died 17 mo. 
100 A 0 1:128 (Anti-A) Died 308 days 
102 B 0 1 :512 (Anti-B) Retransplant 16 days 
Died 73 days 
104 B A 1:128 (Anti-B) Died 6 mo. 
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Table 6. HL-A Typing of Primary Hepatic Grafts in 103 Cases 
SURVIVAL 
MATCH' NUMBER 1 YEAR 
A 1 It 
B 3 1 (33 per cent) 
C 15 3 (20 per cent) 
D 27 5 (19 per cent) 
E 44 16 (36 per cent) 
F 6 1 (17 per cent) 
Not done 7 1 (14 per cent) 
TOTAL 103 27 (29 per cent) 
'A-Match: HL-A identity between recipient and donor. 
B-Match: Compatibility between donor and recipient, but fewer antigens determined 
in'the donor. 
C-Match: One antigen incompatible_ 
D-Match: Two antigens incompatible. 
E-Match: Three or four antigens incompatible. 
F -Match: ABO violation or positive crossmatch to cytotoxic antibodies. 
tRetransplanted after 68 days with C-Match graft. Thus, the I-year survival was due 
mainly to the second less well matched organ. 
- -. 
TECHNIQUES OF ORTHOTOPIC LIVER TRANSPLANTATION 
The surgical techniques of orthotopic liver transplantation have 
largely become standardized. The vena cava is anastomosed to the 
analogous host vessels above and below the liver (Fig. 3), The portal 
venous anastomosis is an end-to-end one and the hepatic artery is usual-
ly revascularized with the common hepatic artery of the recipient_ 
~ , 
Figure 3. Techniques of biliary 
duct reconstruction used in conjunc-
tion with liver transplantation: A, 
cholecystoduodenostomy; B, chole-
cystojejunostomy; C, choledocho-
jejunostomy after removal of gall-
bladder; D, choledochocholedo-
chostomy. Note that the T-tube is 
placed, if possible, in the recipient 
common duct. (Reproduced from 
Stanl. T_ E., Porter, K. A., Putnam, 
C. W., et aI.: Orthotopic liver trans-
plantation in 93 patients. Surg. 
Gynec. Obstet., 142:487, 1976. Used 
with permission.) 
1. 
! 
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The major technical problems have arisen from failure to achieve or 
maintain satisfactory biliary drainage. Until 1973, the usual technique 
for restoring biliary continuity was with cholecystoduodenostomy (Fig. 
3A). There were definite pitfalls to this approach. First, in a few cases, 
technical errors were made at the time of transplantation because of the 
failure to recognize cystic duct anomalies in the donor. In these instances, 
the cystic duct was occluded when the common duct was ligated prior to 
performing cholecystoduodenostomy. Accordingly, operative cholangiog-
raphy became a routine in the donor room several years ago. 
Even though satisfactory biliary drainage was achieved initially by 
cholecystoenterostomy, this was no guarantee that obstruction might not 
occur later. When obstruction did occur-and it has in about a third of the 
cases in which the gallbladder was used for anastomosis-it was always 
at the level of the cystic duct. With obstruction, a syndrome of jaundice, 
fever, septicemia, and biochemical evidence of cholangitis developed. In 
the first few cases, the correct diagnosis was not made until autopsy. 
Subsequently, several cases were diagnosed during life by operative 
cholangiography. keverthel~ssI reoperation was usually too late, the pa-
tients dying of septic complications. 
In 1973, we adopted a policy of performing transhepatic cholangiog-
raphy whenever recurrent jaundice appeared after transplantation. For 
this purpose, we have used the Yery thin needle developed in Chiba, 
Japan, the so-called "Chiba" or "skinny" needle. With this technique, the 
procedure has proved to be quite safe and immensely helpful. 
If obstruction of the cystic duct is diagnosed with transhepatic cho-
langiography, the patient is promptly reoperated and a secondary anas-
tomosis is performed using the dilated common duct (Figs. 3C and 4). 
Transhepatic cholangiography is equally valuable if a normal duct 
system is demonstrated. If the Clinicalpicture suggests rejection, prompt 
intensification of steroid therapy is made. Needle biopsy of the liver is 
helpful in confirming the diagnosis, particularly if drug hepatotoxicity 
appears to be an alternate possibility. 
In addition to the adoption offrequent transhepatic cholangiography, 
a second change has been made with regard to biliary drainage. It gradu-
ally became apparent that cholangitis and systemic sepsis were fre-
quently being encountered even without mechanical obstruction. With 
cholecystoduodenostomy the biliary tract is in direct continuity with the 
mainstream gastrointestinal tract (see Fig. 3A). By interposing a long, 
defunctionalized Roux-en-Y limb of jejunum between the biliary tree and 
the gastrointestinal tract it was hoped that the frequency of hepatic sepsis 
would thereby be reduced. If cystic duct obstruction occurs, the gallblad-
der is removed and a choledochojejunostomy performed (Fig. 3C). 
Despite these improvements, the provision of satisfactory biliary 
drainage remains the fundamental technological problem in liver trans-
plantation. Certain principles of reconstruction have emerged, however. 
Ideally, the biliary reconstruction should avoid using the cystic duct with 
its inherently high risk of obstruction. Secondly, the liver should be pro-
tected from the bacterially-contaminated mainstream gastrointestinal 
tract, either by a defunctionalized Roux-en-Y limb of jejunum or by the 
sphincter of Oddi. And thirdly, radiographic visualization of the biliary 
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Figure 4 . Transhepatic cholangiography after liver replacement demonstrating cystic 
duct obstruction after cholecystoenterostomy. A, Original procedure was cholecystoduodenos-
tomy. After this transhepatic cholangiogram, conversion was made to choledochoduodenos-
tomy. At operation, the filling defect near the exit of the cystic duct was found to consist of a 
chalk-like sludge. There was not complete reliefofjaundice. When the patient died 13 months 
after transplantation, the homograft still had intrahepatic e\idence oflarge duct obstruction. 
B, The original reconstruction was with cholecysto-Roux-en·Y-jejunostomy. This was con-
verted to a choledochojejunostomy. The patient is well almost 2 years later. C, The original 
reconstruction was with cholecysto-Roux-en·Y-jejunostomy. This was converted to a 
choledochojejunostomy. The patient is well about 2'/2 years later. (CD, common bile duct; 
CyD, cystic duct; GB, gallbladder;] , Roux·en-Y limb of jejunum.) 
tree, either by direct tube cholangiography or by the transhepatic ap-
proach, must be obtained if jaundice, cholangitis, or systemic sepsis 
occurs. Choledochocholedochostomy with T-tube drainage satisfies these 
criteria, but carries a much higher risk of bile fistula than cholecystoen-
terostomy (Fig. 3D). Alternatively, choledochojejunostomy may be feasi-
ble in some cases, although the small size of the normal donor common 
duct makes this a difficult primary anastomosis. When it is used, stenting 
of the anastomosis with a small Silastic catheter allows sampling of the 
bile. frequent cholangiography. and may reduce the incidence of fistula 
formation. 
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It seems clear that no one kind of biliary reconstruction will be satis-
factory for all patients and that techniques of reconstruction must be 
individualized in each case. 
THE FUTURE OF LIVER TRANSPLANTATION 
Fifteen years ago, few surgeons or nephrologists would have pre: 
dieted that renal transplantation would be so phenomenally successful, 
much less that it would become a socialized form of medical therapy, 
financed by the Federal Government! 
Does the same promise hold true for hepatic transplantation? No 
longer in its infancy (it has been almost 10 years since the first long-term 
survivor was treated), liver transplantation as it enters adolescence still 
faces an uncertain future. The technical problems surrounding this pro-
cedure have largely been solved with one glaring exception, the problem 
of reestablishing biliary drainage. During the last 3 or 4 years, refine-
ments in the surgical techniques of reconstruction, a better appreciation 
of the role of bacterial contamination, and recently developed diagnostic 
techniques such as transhepatic cholangiography have all contributed to 
a better understanding of past fahures and provide a road map for future 
progress. The precise application of these lessons should reduce the early 
mortality after this procedure. The accurate and early diagnosis of biliary 
tract problems wiI! also indirectly reduce the incidence of non-graft re-
lated septic complications, since "obstruction masquerading as rejec-
tion" has frequently led to unnecessary, inopportune, and frequently fatal 
overimmunosuppression. 
Even with the prevention or pe11'ect management of biliary tract 
complications, a number of grafts-and patients-will continue to be lost 
from rejection. A greater willingness to accept the need for retransplan ta-
tion rather than pursuing aggressive immunosuppression may reduce 
patient mortality just as has this policy following cadaveric renal trans-
plantation. Obviously, the technical obstacles to replacing a hepatic 
homograft are considerably more formidable than for providing a second 
renal transplant, but retransplantation may prove to be a more acceptable 
alternative than the frequently lethal consequences of heavy steroid 
therapy. 
Still, as with transplantation of the kidney, heart, bone marrow, and 
other organs, real hope for wide clinical applicability rests with an im-
provement in immunosuppression that would allow cadaveric organs to 
be transplanted with the relative ease accompanying the transfer of re-
lated homografts. 
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